Thursday Nov 02, 2023

All into Account: ‘The broader impact of GLP-1s’ with Chris Schott, Robbie Marcus, Andrea Teixeira, Ken Goldman, Brett Gibson, and Carla Casella

We expect GLP-1s will be an important theme now and in the years to come, so we’ve gathered up both the Stock and Credit analysts for a number of sectors including Pharmaceuticals, Med Tech, Food, Beverages, Healthcare, Insurance, Retail etc. to get an overview of the broad impact.


Thomas Salopek, Head of Global Cross Asset Strategy
Chris Schott, Pharmaceuticals Analyst
Robbie Marcus, Medical Supplies & Devices Analyst
Andrea Teixeira, Beverage, Household & Personal Care Products Analyst
Ken Goldman, Food Producers & Retailers Analyst
Brett Gibson, US Credit Analyst: Healthcare and Insurance
Carla Casella, US Credit Analyst: Food, Beverages, Tobacco, Consumer products, Retail


This podcast was recorded on Nov 01, 2023.
This communication is provided for information purposes only. Institutional clients can view the related reports at,, for more information; please visit for important disclosures. © 2023 JPMorgan Chase & Co. All rights reserved.

Copyright 2022 All rights reserved.

Version: 20240320